Filing Flows › Bio-Techne (TECH) › Q4 FY26 › vs Q3 FY26
Bio-Techne (TECH) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Bio-Techne's revenue rose $9.8M (+3%) from $311M in Q3 FY26 to $321M in Q4 FY26. The biggest changes: Product and Services +$8.9M (+3%); Royalty +$898K (+18%). Gross margin 65.8% against 66.9% (-1.1 pts).
Bio-Techne, Q4 FY26: revenue $321M (+1% year over year), operating margin 23.1%, net earnings $54.6M, operating cash flow $95.4M. The chart draws each line against Q3 FY26, the increases inside each band.
Margins
| Q4 FY26 | Q3 FY26 | Change | |
|---|---|---|---|
| Gross margin | 65.8% | 66.9% | -1.1 pts |
| Operating margin | 23.1% | 24.2% | -1.1 pts |
| Net margin | 17.0% | 16.4% | +0.6 pts |
| Free cash flow margin | 27.1% | 24.9% | +2.2 pts |
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Consumables | $261M | $257M | $3.4M | +1% |
| Instruments | $31.5M | $27.7M | $3.9M | +14% |
| Services | $23.1M | $21.4M | $1.6M | +8% |
| Product and Services | $315M | $306M | $8.9M | +3% |
| Royalty | $5.9M | $5.0M | $898K | +18% |
| Revenue | $321M | $311M | $9.8M | +3% |
| Gross profit | $211M | $208M | $3.1M | +1% |
| Cost of revenue | $110M | $103M | $6.7M | +6% |
| Operating profit | $74.3M | $75.5M | −$1.2M | -2% |
| Operating expenses | $137M | $133M | $4.3M | +3% |
| Pre-tax earnings | $70.7M | $71.2M | −$545K | -0.8% |
| Other expense, net | $3.6M | $4.3M | −$674K | -16% |
| Research & development | $23.9M | $23.5M | $490K | +2% |
| SG&A | $113M | $109M | $3.8M | +4% |
| Net earnings | $54.6M | $51.0M | $3.6M | +7% |
| Income tax | $16.1M | $20.2M | −$4.1M | -20% |
| Depreciation & amortization | $24.1M | $24.2M | −$28K | -0.1% |
| Share-based compensation | $5.2M | $10.5M | −$5.3M | -50% |
| Working capital & other | $11.4M | $950K | $10.5M | 12× |
| Operating cash flow | $95.4M | $86.7M | $8.8M | +10% |
| Free cash flow (OCF − capex) | $86.9M | $77.6M | $9.4M | +12% |
| Capital expenditures | $8.5M | $9.1M | −$606K | -7% |
Questions
How much did Bio-Techne's revenue grow quarter over quarter in Q4 FY26?
Bio-Techne's revenue rose $9.8M (+3%) from $311M in Q3 FY26 to $321M in Q4 FY26.
What drove Bio-Techne's revenue change in Q4 FY26?
Product and Services +$8.9M (+3%); Royalty +$898K (+18%).